| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.0M | +72.8% |
| Cost of Revenue | $34.7M | +120.2% |
| Gross Profit | $2.3M | -59.0% |
| R&D Expense | $2.3M | +18.6% |
| SG&A Expense | $32.1M | +56.9% |
| Operating Income | -$29.7M | -101.4% |
| Interest Expense | $37K | +30.1% |
| Pre-tax Income | -$18.9M | -173.9% |
| Net Income | -$18.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.5M | -89.0% |
| Accounts Receivable | $2.0M | -25.0% |
| Inventory | $6.8M | -29.2% |
| Current Assets | $25.0M | -55.5% |
| Total Assets | $56.7M | -31.7% |
| Current Liabilities | $13.5M | -41.3% |
| Long-term Debt | $928K | -17.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.6M | -4.2% |
| Capital Expenditures | $2.1M | -67.8% |
| Investing Cash Flow | -$2.9M | +84.6% |
| Financing Cash Flow | -$7.0M | -110.8% |
| Free Cash Flow | -$20.6M | +14.9% |
| -174.1% |
| EPS (Basic) | -$8.50 | -1766.7% |
| EPS (Diluted) | -$8.50 | -1766.7% |
| Total Liabilities |
| $20.3M |
| -25.1% |
| Stockholders' Equity | $36.3M | -34.9% |